{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:42:40Z","timestamp":1790685760136,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,29]],"date-time":"2020-02-29T00:00:00Z","timestamp":1582934400000},"content-version":"am","delay-in-days":304,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01-MH083784"],"award-info":[{"award-number":["R01-MH083784"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1 RR024131"],"award-info":[{"award-number":["UL1 RR024131"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jad.2019.02.063","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T11:22:35Z","timestamp":1551180155000},"page":"65-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"special_numbering":"C","title":["Plasma serotonin levels are associated with antidepressant response to SSRIs"],"prefix":"10.1016","volume":"250","author":[{"given":"Amanda","family":"Holck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0655-5042","authenticated-orcid":false,"given":"Owen M","family":"Wolkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sindy H","family":"Mellon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor I","family":"Reus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Craig","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5sa","family":"Westrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3472-327X","authenticated-orcid":false,"given":"Daniel","family":"Lindqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2019.02.063_bib0001","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s002130050924","article-title":"Plasma serotonin level after 1 day of fluoxetine treatment: a biological predictor for antidepressant response?","volume":"143","author":"Alvarez","year":"1999","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.jad.2019.02.063_bib0002","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.bbagen.2012.05.012","article-title":"Correlation of serotonin levels in CSF, platelets, plasma, and urine","volume":"1820","author":"Audhya","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jad.2019.02.063_bib0003","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00004714-200204000-00005","article-title":"Serotonin and fluoxetine levels in plasma and platelets after fluoxetine treatment in depressive patients","volume":"22","author":"Blardi","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2019.02.063_bib0004","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/01.jcp.0000161500.58266.90","article-title":"Activity of citalopram on adenosine and serotonin circulating levels in depressed patients","volume":"25","author":"Blardi","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2019.02.063_bib0005","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1476-5381.1993.tb13817.x","article-title":"The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain","volume":"110","author":"Caccia","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jad.2019.02.063_bib0006","first-page":"102","article-title":"Can serotonin and fluoxetine levels in plasma and platelets predict clinical response in depression?","volume":"37","author":"Castrogiovanni","year":"2003","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jad.2019.02.063_bib0007","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0165-0327(92)90082-H","article-title":"Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients. Relationship to clinical improvement","volume":"25","author":"Celada","year":"1992","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2019.02.063_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/IJTR.S2097","article-title":"Kynurenine pathway metabolites in humans: disease and healthy states","volume":"2","author":"Chen","year":"2009","journal-title":"Int. J. Tryptophan. Res."},{"key":"10.1016\/j.jad.2019.02.063_bib0009","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1476-5381.1979.tb07878.x","article-title":"Content and subcellular localization of catecholamines and 5-hydroxytryptamine in human and animal blood platelets: monoamine distribution between platelets and plasma","volume":"65","author":"Da Prada","year":"1979","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jad.2019.02.063_bib0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1758-2946-2-9","article-title":"Organization of GC\/MS and LC\/MS metabolomics data into chemical libraries","volume":"2","author":"Dehaven","year":"2010","journal-title":"J. Cheminform."},{"key":"10.1016\/j.jad.2019.02.063_bib0011","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1021\/ac901536h","article-title":"Integrated, nontargeted ultrahigh performance liquid chromatography\/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems","volume":"81","author":"Evans","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jad.2019.02.063_bib0012","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10522-012-9406-3","article-title":"Serotonin: from top to bottom","volume":"14","author":"Fidalgo","year":"2013","journal-title":"Biogerontology"},{"key":"10.1016\/j.jad.2019.02.063_bib0013","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0006-3223(98)00344-8","article-title":"Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depression","volume":"46","author":"Figueras","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2019.02.063_bib0014","series-title":"Structured Clinical Interview For DSM-IV Axis I Disorders","author":"First","year":"1997"},{"key":"10.1016\/j.jad.2019.02.063_bib0015","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0024-3205(00)00620-2","article-title":"Serotonergic platelet variables in unmedicated patients suffering from major depression and healthy subjects: relationship between 5HT content and 5HT uptake","volume":"67","author":"Franke","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.jad.2019.02.063_bib0016","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1038\/mp.2016.6","article-title":"TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics","volume":"21","author":"Gupta","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2019.02.063_bib0017","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2019.02.063_bib0018","doi-asserted-by":"crossref","first-page":"e6797","DOI":"10.1371\/journal.pone.0006797","article-title":"Chronic citalopram administration causes a sustained suppression of serotonin synthesis in the mouse forebrain","volume":"4","author":"Honig","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2019.02.063_bib0019","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.euroneuro.2015.12.039","article-title":"The 5-HT1A receptor in major depressive disorder","volume":"26","author":"Kaufman","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2019.02.063_bib0020","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/01.jcp.0000138765.08235.46","article-title":"Early effects of paroxetine on serotonin storage, plasma levels, and urinary excretion: a randomized, double-blind, placebo-controlled trial","volume":"24","author":"Kotzailias","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2019.02.063_bib0021","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(69)91140-4","article-title":"Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect","volume":"1","author":"Lapin","year":"1969","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2019.02.063_bib0022","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1017\/S1461145704004699","article-title":"Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response","volume":"7","author":"Lemonde","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2019.02.063_bib0023","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jad.2015.08.025","article-title":"Decreased platelet 5-hydroxytryptamin (5-HT) levels: a response to antidepressants","volume":"187","author":"Li","year":"2015","journal-title":"J. Affect. Disord."},{"issue":"Suppl 1","key":"10.1016\/j.jad.2019.02.063_bib0024","first-page":"57","article-title":"Modulating the serotonin system in the treatment of major depressive disorder","volume":"19","author":"Morrissette","year":"2014","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2019.02.063_bib0025","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/0192623309336152","article-title":"Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in Fischer 344 male rats","volume":"37","author":"Ohta","year":"2009","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.jad.2019.02.063_bib0026","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejphar.2009.11.037","article-title":"A longitudinal study of 5-HT outflow during chronic fluoxetine treatment using a new technique of chronic microdialysis in a highly emotional mouse strain","volume":"628","author":"Popa","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jad.2019.02.063_bib0027","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neuron.2009.12.003","article-title":"5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants","volume":"65","author":"Richardson-Jones","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.jad.2019.02.063_bib0028","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.mp.4001949","article-title":"Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies","volume":"12","author":"Ruhe","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2019.02.063_bib0029","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0377-1237(09)80120-2","article-title":"Serum serotonin abnormality in depression","volume":"65","author":"Saldanha","year":"2009","journal-title":"Med. J. Armed Forces India"},{"key":"10.1016\/j.jad.2019.02.063_bib0030","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1471-4159.1990.tb02319.x","article-title":"Relationship between serotoninergic measures in blood and cerebrospinal fluid simultaneously obtained in humans","volume":"54","author":"Sarrias","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jad.2019.02.063_bib0031","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/1098-2396(20001215)38:4<460::AID-SYN11>3.0.CO;2-D","article-title":"In vivo microdialysis assessment of extracellular serotonin and dopamine levels in awake monkeys during sustained fluoxetine administration","volume":"38","author":"Smith","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.jad.2019.02.063_bib0032","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/archpsyc.1977.01770170019001","article-title":"The human platelet. A diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders","volume":"34","author":"Stahl","year":"1977","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2019.02.063_bib0033","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.euroneuro.2015.06.007","article-title":"Inflammation and clinical response to treatment in depression: a meta-analysis","volume":"25","author":"Strawbridge","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2019.02.063_bib0034","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/archpsyc.63.11.1217","article-title":"Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis","volume":"63","author":"Taylor","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2019.02.063_bib0035","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2019.02.063_bib0036","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0192-0561(99)00035-1","article-title":"[3H]Paroxetine binding to human peripheral lymphocyte membranes of patients with major depression before and after treatment with fluoxetine","volume":"21","author":"Urbina","year":"1999","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.jad.2019.02.063_bib0037","series-title":"Depression and Other Common Mental Disorders: Global Health Estimates","year":"2017"},{"key":"10.1016\/j.jad.2019.02.063_bib0038","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0031-9384(96)00497-0","article-title":"The effects of dieting on plasma tryptophan concentration and food intake in healthy women","volume":"61","author":"Wolfe","year":"1997","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.jad.2019.02.063_bib0039","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.comppsych.2014.09.007","article-title":"How many different ways do patients meet the diagnostic criteria for major depressive disorder?","volume":"56","author":"Zimmerman","year":"2015","journal-title":"Compr. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032718328696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032718328696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:21:50Z","timestamp":1759022510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032718328696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":39,"alternative-id":["S0165032718328696"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2019.02.063","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma serotonin levels are associated with antidepressant response to SSRIs","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2019.02.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}